Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

Modified-Release Drug Delivery Systems: Overview

Modified-Release Drug Delivery Systems: Overview

Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...

Drug Dosage Regimen: Overview

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

Oral Drug Delivery Systems: Continuous-Release Systems

Oral Drug Delivery Systems: Continuous-Release Systems

Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Dosage Regimen: Fixed Dose

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Warfarin Patient Self-Management in the US Health Care System: A Nonrandomized Clinical Trial.

JAMA network open·2026

Same author

Characterisation of real-world patients who discontinued a glucagon-like peptide-1 agonist.

Diabetes, obesity & metabolism·2026

Same author

A Multi-Intervention Approach to Blood Pressure Control: A Description of How a Large University Based Primary Care Clinic Tackled Hypertension.

Population health management·2025

Same author

Improving Access to Rheumatology Care: Evaluation of a Rheumatology Electronic Consultation Program.

Arthritis care & research·2025

Same author

Primary care physicians prescribe fewer expensive combination medications than dermatologists for acne: A retrospective review.

Journal of managed care & specialty pharmacy·2025

Same author

Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritis.

Expert opinion on biological therapy·2025

Search research articles

Related Experiment Video

Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Outcomes of a pharmacist-managed medication refill program.

Sarah J Billups, Thomas Delate, Carey Newlon

Journal of the American Pharmacists Association : Japha

|September 14, 2013

Summary

This summary is machine-generated.

A pharmacist-managed medication refill and laboratory monitoring program (MRLMP) improved medication and blood pressure monitoring completeness. This enhanced patient care and satisfaction while reducing primary care physician workload.

Related Experiment Videos

Last Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Area of Science:

Health Services Research
Pharmacy Practice
Primary Care

Background:

Medication adherence and monitoring are crucial for chronic disease management.
Traditional medication refill processes may not adequately address necessary monitoring.
Pharmacist involvement in medication management can potentially improve patient outcomes.

Purpose of the Study:

To compare the effectiveness of a pharmacist-managed medication refill and laboratory monitoring program (MRLMP) against usual care.
To evaluate improvements in medication and blood pressure monitoring completeness.
To assess satisfaction levels among pharmacists, primary care physicians (PCPs), and patients.

Main Methods:

A quasiexperimental study was conducted at Kaiser Permanente Colorado from November 2011 to June 2012.
The intervention involved community pharmacists managing the refill authorization request (RAR) process, including ordering necessary laboratory tests or clinic visits.
The study compared the 1-month rate of complete monitoring for medications due for laboratory or blood pressure checks between the MRLMP and usual care groups.

Main Results:

The MRLMP group showed significantly higher rates of laboratory monitoring (49% vs. 29%) and blood pressure monitoring (56% vs. 33%) compared to the usual care group.
Primary care physicians in the MRLMP group reported higher satisfaction with the RAR process and spent less time on refill requests.
Pharmacists in the MRLMP group reported higher job satisfaction, and patients reported greater satisfaction with prescription readiness.

Conclusions:

A pharmacist-managed MRLMP significantly improved process-related outcomes, including monitoring completeness and satisfaction.
The program demonstrated efficiency gains by reducing PCP workload.
Further research is recommended to evaluate the clinical outcomes associated with this pharmacist-led program.